Assenagon Asset Management
IART icon

Assenagon Asset Management’s Integra LifeSciences IART Stock Holding History

Assenagon Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.53M Sell
140,633
-276,774
-66% -$3.87M ﹤0.01% 811
2026
Q1 		$3.93M Sell
417,407
-108,895
-21% -$1.2M 0.01% 634
2025
Q4 		$6.54M Buy
526,302
+71,950
+16% +$957K 0.01% 598
2025
Q3 		$6.51M Sell
454,352
-739,827
-62% -$10.1M 0.01% 567
2025
Q2 		$14.7M Sell
1,194,179
-605,765
-34% -$8.8M 0.02% 404
2025
Q1 		$39.6M Buy
1,799,944
+1,728,480
+2,419% +$40.6M 0.07% 242
2024
Q4 		$1.62M Sell
71,464
-21,053
-23% -$460K ﹤0.01% 1003
2024
Q3 		$1.68M Sell
92,517
-4,178
-4% -$96.8K ﹤0.01% 1011
2024
Q2 		$2.82M Buy
+96,695
New +$2.87M 0.01% 799
2024
Q1 		– Sell
-475,409
Closed -$20.7M – 1421
2023
Q4 		$20.7M Sell
475,409
-190,823
-29% -$7.51M 0.06% 282
2023
Q3 		$25.4M Buy
+666,232
New +$28M 0.08% 207
2021
Q1 		– Sell
-7,203
Closed -$468K – 1245
2020
Q4 		$468K Sell
7,203
-89,473
-93% -$4.81M ﹤0.01% 859
2020
Q3 		$4.57M Buy
+96,676
New +$4.6M 0.03% 349

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Assenagon Asset Management's IART Position: Q2 2026 in Review

Assenagon Asset Management reduced its Integra LifeSciences (IART) stake by 66% in Q2 2026, selling an estimated $3.87M and leaving 140,633 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #811.

Assenagon Asset Management first reported a position in IART in Q3 2020 and has held it in 13 quarters since. The position peaked at $39.6M in Q1 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Assenagon Asset Management held 140,633 shares of Integra LifeSciences worth $2.53M as of Q2 2026.
  • Assenagon Asset Management sold 276,774 Integra LifeSciences shares in Q2 2026, an estimated $3.87M.
  • Integra LifeSciences made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #811 holding.
  • Assenagon Asset Management first reported a position in Integra LifeSciences in Q3 2020 and has held it in 13 quarters since.
  • Assenagon Asset Management's Integra LifeSciences position peaked at $39.6M in Q1 2025.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.